WO1996040763A3 - Peptides for hiv-1 detection - Google Patents

Peptides for hiv-1 detection Download PDF

Info

Publication number
WO1996040763A3
WO1996040763A3 PCT/US1996/009655 US9609655W WO9640763A3 WO 1996040763 A3 WO1996040763 A3 WO 1996040763A3 US 9609655 W US9609655 W US 9609655W WO 9640763 A3 WO9640763 A3 WO 9640763A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
hiv
detection
point mutation
immunoassays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/009655
Other languages
French (fr)
Other versions
WO1996040763A2 (en
Inventor
Dominique P Bridon
Isaac S-Y Sze
David J Daghfal
Keeve D Jaffe
Tracey L Colpitts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to EP96921412A priority Critical patent/EP0832113B1/en
Priority to DE69632535T priority patent/DE69632535T2/en
Priority to JP50192997A priority patent/JP3889045B2/en
Publication of WO1996040763A2 publication Critical patent/WO1996040763A2/en
Publication of WO1996040763A3 publication Critical patent/WO1996040763A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

HIV-1 peptides having at least one point mutation between position 593 and 611 of the HIV-1 gp 160 amino acid sequence. The point mutation either is at position 604 or 610, or both positions. Immunoassays which utilize these peptides are provided, as well as, diagnostic test kits which contain these peptides.
PCT/US1996/009655 1995-06-07 1996-06-07 Peptides for hiv-1 detection Ceased WO1996040763A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96921412A EP0832113B1 (en) 1995-06-07 1996-06-07 Peptides for hiv-1 detection
DE69632535T DE69632535T2 (en) 1995-06-07 1996-06-07 PEPTIDES FOR DETECTING HIV-1
JP50192997A JP3889045B2 (en) 1995-06-07 1996-06-07 Peptides for detecting HIV

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47259795A 1995-06-07 1995-06-07
US08/472,597 1995-06-07

Publications (2)

Publication Number Publication Date
WO1996040763A2 WO1996040763A2 (en) 1996-12-19
WO1996040763A3 true WO1996040763A3 (en) 1997-02-06

Family

ID=23876162

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/009655 Ceased WO1996040763A2 (en) 1995-06-07 1996-06-07 Peptides for hiv-1 detection

Country Status (7)

Country Link
US (1) US5800983A (en)
EP (1) EP0832113B1 (en)
JP (1) JP3889045B2 (en)
CA (1) CA2222994A1 (en)
DE (1) DE69632535T2 (en)
ES (1) ES2220982T3 (en)
WO (1) WO1996040763A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074646A (en) * 1993-10-26 2000-06-13 Board Of Regents, The University Of Texas System Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
US6828157B1 (en) * 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) * 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
AU1090101A (en) * 1999-10-15 2001-04-30 Peptide Solutions, Inc. Hiv-1 subtype d peptides
AU2003212466A1 (en) * 2002-02-28 2003-09-16 Board Of Regents, The University Of Texas System Method and composition for detecting early hiv antibody
CA2525640C (en) * 2003-04-11 2014-10-07 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Multiple antigenic peptide assay for detection of hiv or siv type retroviruses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007119A1 (en) * 1988-12-20 1990-06-28 Immunodiagnostics, Inc. Synthetic hiv-like peptides, their compositions and uses
EP0591914A2 (en) * 1992-10-06 1994-04-13 BEHRINGWERKE Aktiengesellschaft Retrovirus of the HIV-group and its application
DE4405810A1 (en) * 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
EP0727483A2 (en) * 1995-02-16 1996-08-21 BEHRINGWERKE Aktiengesellschaft Retrovirus of the HIV-group and its application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0657532B1 (en) * 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 retrovirus strains and their use
US5089424A (en) * 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5075077A (en) * 1988-08-02 1991-12-24 Abbott Laboratories Test card for performing assays
US5320808A (en) * 1988-08-02 1994-06-14 Abbott Laboratories Reaction cartridge and carousel for biological sample analyzer
ES2066887T3 (en) * 1989-02-03 1995-03-16 Abbott Lab MONOCLONAL ANTIBODY TO DIFFERENT HIV-2 SEROPOSITIVE INDIVIDUALS FROM HIV-1.
WO1990012852A1 (en) * 1989-04-14 1990-11-01 Procedes Petroliers Et Petrochimiques Process for steam-cracking hydrocarbons

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007119A1 (en) * 1988-12-20 1990-06-28 Immunodiagnostics, Inc. Synthetic hiv-like peptides, their compositions and uses
EP0591914A2 (en) * 1992-10-06 1994-04-13 BEHRINGWERKE Aktiengesellschaft Retrovirus of the HIV-group and its application
DE4405810A1 (en) * 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
EP0727483A2 (en) * 1995-02-16 1996-08-21 BEHRINGWERKE Aktiengesellschaft Retrovirus of the HIV-group and its application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
P. CHARNEAU ET AL.: "Isolation and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group", VIROLOGY, vol. 205, no. 1, 15 November 1994 (1994-11-15), ORLANDO US, pages 247 - 253, XP002020448 *

Also Published As

Publication number Publication date
JP3889045B2 (en) 2007-03-07
WO1996040763A2 (en) 1996-12-19
JPH11507635A (en) 1999-07-06
DE69632535D1 (en) 2004-06-24
EP0832113B1 (en) 2004-05-19
US5800983A (en) 1998-09-01
EP0832113A2 (en) 1998-04-01
ES2220982T3 (en) 2004-12-16
DE69632535T2 (en) 2005-06-02
CA2222994A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
CA2166291A1 (en) Htlv-iinra compositions and assays for detecting htlv infection
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
CA2124953A1 (en) Peptides related to prion proteins
CA2220447A1 (en) Novel fusion protein recovery and purification methods
CA2336153A1 (en) Method for early diagnosis of carcinomas
EP0891982A3 (en) HIV peptides
CA2239692A1 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
CA2530927A1 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
CA2203765A1 (en) Cathepsin o2 protease
AU5327386A (en) Peptide derivatives, analogous to pepstatin, which inhibit renin and acid proteases.
CA2177827A1 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
WO1999020747A3 (en) HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
WO1997029199A3 (en) Prostate specific antigen peptides and uses thereof
CA2266850A1 (en) Methods and compositions for the diagnosis of extraesophageal gastric reflux
EP1452540A3 (en) Molecular sequence of swine retrovirus and methods of use
WO1996040763A3 (en) Peptides for hiv-1 detection
GB2342652A (en) Polypeptides comprising a coiled-coil and an addition
TR199801027T2 (en) Method for diagnosis and treatment of epithelioma.
CA2253236A1 (en) Methods and kits for the detection of endotoxin
CA2004885A1 (en) Anticoagulant peptides
CA2155001A1 (en) Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
AU1690899A (en) Method for testing crohn's disease and testing kit therefor
CA2080408A1 (en) Artificial standard and control sera, processes for the preparation thereof and the use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2222994

Country of ref document: CA

Ref country code: CA

Ref document number: 2222994

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996921412

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 501929

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996921412

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1996921412

Country of ref document: EP